Migraine. The promotion of prescription drugs directly to the public is not allowed in the European Union. But see the Ajovy case in Spain: direct-to-consumer news, the blurred margin between propaganda and information.
15 Mar
It seems that Teva’s commercial strategy includes promoting fremanezumab (Ajovy) to the general public (direct-to-consumer). Vall d’Hebron Hospital (Barcelona, Spain) supports and presents as a novelty something that “offers nothing new”. Such promotion is clearly prohibited by Spanish and European legislation. It is also accompanied by an incredible and constant “apparatus” of pressure on those [...]



